Canadian General Medical Center Complex Company (TADAWUL:4021)

TADAWUL:4021 Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	10.5	10.27	15.71	15.65	14.06
Depreciation & Amortization	6.52	4.03	1.74	3.14	2.94
Loss (Gain) From Sale of Assets	0	0.01	0.04	0	-0
Loss (Gain) From Sale of Investments	4.95	-0.07	-	-0.23	-0.38
Provision & Write-off of Bad Debts	1.87	0.38	6.47	0.6	0.22
Other Operating Activities	1.29	0.75	-0.16	0.3	2.87
Change in Accounts Receivable	-19.35	-7.21	-9.16	-0.76	-17.4
Change in Inventory	-0.44	0.71	0.43	-2.65	-1.72
Change in Accounts Payable	10.84	0.93	0.48	0.62	1.98
Change in Other Net Operating Assets	3.7	-5.66	-2.79	-0.15	-0.98
Operating Cash Flow	19.88	4.13	12.77	16.53	1.59
Operating Cash Flow Growth	380.79%	-67.62%	-22.77%	939.31%	-91.08%
Capital Expenditures	-9.36	-8.03	-3.37	-0.1	-1.64
Sale of Property, Plant & Equipment	0.05	0.11	0.08	-	0.01
Investment in Securities	0.01	-35	45.92	14.66	-59
Investing Cash Flow	-9.3	-42.92	42.63	14.56	-60.63
Short-Term Debt Repaid	-	-	-	-2.76	-1.86
Long-Term Debt Repaid	-3.34	-2.98	-1.14	-1.09	-0.95
Total Debt Repaid	-3.34	-2.98	-1.14	-3.84	-2.82
Net Debt Issued (Repaid)	-3.34	-2.98	-1.14	-3.84	-2.82
Common Dividends Paid	-7.7	-6.93	-11.55	-23.1	-11.55
Financing Cash Flow	-11.04	-9.91	-12.69	-26.94	-14.37
Net Cash Flow	-0.46	-48.7	42.71	4.14	-73.41
Free Cash Flow	10.52	-3.9	9.39	16.43	-0.05
Free Cash Flow Growth	-	-	-42.83%	-	-
Free Cash Flow Margin	7.10%	-3.52%	9.36%	20.23%	-0.06%
Free Cash Flow Per Share	0.14	-0.05	0.12	0.21	-0.00
Cash Interest Paid	-	-	-	0.05	0.07
Levered Free Cash Flow	5.47	-7.5	3.17	11.44	-4.8
Unlevered Free Cash Flow	5.82	-7.18	3.38	11.79	-4.58
Change in Working Capital	-5.25	-11.23	-11.03	-2.94	-18.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.